CAMBRIDGE, MA, Vigil Neuroscience, a biotechnology company announced the completion of a $90 million Series B financing led by Vida Ventures. Read More
BOSTON, MA, WeSpire, an employee experience platform for ESG initiatives, has secured $13M in a Series B funding led by Level Structured Capital. Read More